Linola

Urea, the active ingredient in Linola, is a keratolytic presented as a topical preparation for skin application. It helps to hydrate the stratum corneum and reduce hyperkeratosis, making it useful in the management of dry, scaly skin conditions. The product complies with EU quality standards and is marketed as an over‑the‑counter dermatologic agent.

GNH USA supplies Linola as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linola (urea) is applied topically to manage disorders characterized by excessive keratin buildup and skin dryness.

- Ichthyosis: softens thickened scales and improves skin flexibility. - Psoriasis: reduces plaque thickness and scaling. - Xerosis (dry skin): increases hydration and smoothness of the epidermis.

Linola is generally well tolerated, but topical application can be associated with adverse skin reactions.

Common Side Effects: - Mild stinging or burning sensation at the application site. - Transient erythema. - Pruritus. - Slight dryness after initial use. - Minor scaling. - Temporary tingling.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Severe skin irritation or ulceration. - Excessive swelling or edema. - Bullous formation. - Systemic absorption leading to uremic symptoms (very rare). - Anaphylactic reaction.

When using Linola, consider the following safety measures.

- Pregnancy: safety not established; consult a healthcare professional before use. - Breastfeeding: caution advised; discuss with a physician. - Skin integrity: avoid application on broken, inflamed, or infected skin. - Concurrent skin treatments: do not combine with other strong keratolytics without medical guidance. - Allergy: discontinue use if signs of allergic reaction appear. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Linola may interact with other topical agents; monitor for enhanced irritation.

Major Interactions (Avoid): - Concurrent use with potent topical steroids may increase irritation. - Combination with other keratolytic agents (e.g., salicylic acid) may cause excessive skin peeling. - Use with topical retinoids may amplify skin sensitivity.

Moderate Interactions (Monitor Closely): - Application under occlusive dressings may enhance systemic absorption. - Co‑application with moisturizers containing high glycerin concentrations may reduce efficacy. - Concurrent systemic diuretics may affect overall skin hydration balance.